- Jun 19, 2017 -
Chondroitin has been proved to be able to supplement the effect of the structure of the joint soft tissue by oral administration, and the clinical use of chondroitin can effectively relieve the pain and inflammation of arthritis, and also have the effect of delaying the aging of joints. Human clinical trials show that oral chondroitin can increase the secretion of synovial fluid and the concentration of synovial fluid--Hyaluronic acid (Hyaluronic acid), while reducing the activity of chondroitin-decomposing enzymes, delaying the degeneration of the bone joint, there is also a direct injection of hyaluronic acid in the joint site to delay the deterioration of degenerative arthritis of the disease, the use of chondroitin to improve the concentration of hyaluronic acid, is similar to the effect of this medical behavior is expected to achieve the same principle. According to the conclusion of several human clinical studies on oral chondroitin sulfate in recent years, the improvement effect of chondroitin on the clinical symptom of arthritis is about 50% higher than that of the group taking non-steroid analgesic anti-inflammatory drugs (NSAIDs). In the overall medical assessment, compared with those who did not use Chondroitin or glucosamine (please refer to the introduction of glucosamine), at least 25% of the treatment effect, while alone using chondroitin and glucosamine arthritis groups, The improvement in clinical symptoms was comparable (39-40), although the group with a single chondroitin had a slightly higher 1% trend, and the combined treatment with chondroitin and glucosamine was significantly higher than the clinical effect of using either ingredient alone 7-20.